Globus Medical (GMED) reported $2.9B in revenue for fiscal 2025, +16.7% year on year. That ranks #1113 by revenue among 2853 SEC filers and #98 in Healthcare. Net income was $538M, a net margin of 18.3%. Revenue has grown 20.1% a year on average since 2016 ($564M then). The fiscal 2025 balance sheet shows $5.3B in total assets and $526M in cash.
Key figures
| Key figures | FY2025 | YoY | Source |
|---|---|---|---|
| RevenueRevenues | $2.9B | +16.7% | FY20252025-12-31 |
| Gross profitGrossProfit | $1.0B | +34.4% | FY20232023-12-31 |
| Operating incomeOperatingIncomeLoss | $480M | +189.1% | FY20252025-12-31 |
| Net incomeNetIncomeLoss | $538M | +422.3% | FY20252025-12-31 |
| Operating cash flowNetCashProvidedByUsedInOperatingActivities | $753M | +44.7% | FY20252025-12-31 |
| Capital expenditurePaymentsToAcquirePropertyPlantAndEquipment | $165M | +42.7% | FY20252025-12-31 |
| Total assetsAssets | $5.3B | +1.0% | FY20252025-12-31 |
| Shareholders' equityStockholdersEquity | $4.6B | +9.5% | FY20252025-12-31 |
| CashCashAndCashEquivalentsAtCarryingValue | $526M | −32.9% | FY20252025-12-31 |
| Long-term debt | Not reported | — |
Revenue is total net sales for the fiscal year, taken from each company's own annual filing.
Reported since the last full year
Three-month figures this company has filed since FY2025. A quarter is not comparable with a full year, and these figures are used nowhere else on the site: not in any ranking, not in comparisons, not in the download.
| Quarter | Revenue | Net income | Source |
|---|---|---|---|
| Q1 20262026-03-31 | $760M | $124M | Open → |
| Q2 20262026-06-30 | $790M | $152M | Open → |
Only periods that end on a calendar quarter appear here. A company whose fiscal year ends in June files on a different calendar, so it has no row.
Where this sits in its sector
Each bar is the spread of the whole sector: the box covers the middle half of companies, the line inside it the median, and the triangle this company. The axis is clipped at the 5th and 95th percentile so a single outlier does not flatten it.
| Where this sits in its sector | FY2025 | Position in sector |
|---|---|---|
| Net marginRank 26 of 161 companies compared | 18.3% | |
| Operating marginRank 51 of 160 companies compared | 16.3% | |
| R&D as share of revenueRank 75 of 102 companies compared | 5.0% | |
| Cash as share of revenueRank 59 of 160 companies compared | 17.9% |
All four are ratios derived from two reported lines, not single filing items. Peer group: companies in the same sector with revenue of $1bn or more; loss-making companies are included.
Profile
- Legal name
- Globus Medical Inc
- Ticker
- GMED
- Exchange
- NYSE
- SIC classification
- Surgical & Medical Instruments & Apparatus (3841)
- Fiscal year end
- 12-31
- CIK
- 0001237831
Filings
- 10-QAug 6, 2026Open filing →
- 10-QMay 7, 2026Open filing →
- 10-KFeb 24, 2026Open filing →
Similar in size, same sector
| Company | Revenue | Net income |
|---|---|---|
| Minimed GroupMMED | $3.1B | −$333M |
| West Pharmaceutical ServicesWST | $3.1B | $494M |
| Amneal PharmaceuticalsAMRX | $3.0B | $72.1M |
| Globus MedicalGMED | $2.9B | $538M |
| Bright Horizons Family SolutionsBFAM | $2.9B | $193M |
| Neurocrine BiosciencesNBIX | $2.9B | $479M |
| Kindercare Learning CompaniesKLC | $2.7B | −$113M |
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Globus Medical — Key figures |url=https://companiesranked.com/en/company/globus-medical |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Globus Medical — Key figures. CompaniesRanked. https://companiesranked.com/en/company/globus-medicalBibTeX
@misc{companiesranked-en-company-globus-medical-2026,
author = {{CompaniesRanked}},
title = {{Globus Medical — Key figures}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/globus-medical}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-K · 0001628280-26-011209 · February 24, 2026
{{cite web |title=Globus Medical — Key figures — 10-K (0001628280-26-011209) |url=https://www.sec.gov/Archives/edgar/data/1237831/000162828026011209/gmed-20251231.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-02-24}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.